As of 2026-09-25, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -58.44 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 35.50 GBP, the upside of Faron Pharmaceuticals Oy is -264.61%.
Based on its market price of 35.50 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 264.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -58.44 - -58.44 | -58.44 | -264.61% |
| P/E | (57.97) - (137.21) | (67.79) | -290.9% |
| DDM - Stable | (182.63) - 4,063.40 | 1,940.38 | 5365.9% |
| DDM - Multi | (18.70) - 328.56 | (39.98) | -212.6% |
| Market Cap (mil) | 70.85 |
| Beta | 0.49 |
| Outstanding shares (mil) | 2.00 |
| Enterprise Value (mil) | 81.43 |
| Market risk premium | 5.98% |
| Cost of Equity | 6.11% |
| Cost of Debt | 5.00% |
| WACC | 5.88% |